Evaluating the safety of anti‐amyloid monoclonal antibody infusions in alternative sites of care

Christine Miller, Don Filibeck, Lauren Pica, Barbara Prosser · 2025

Read Evaluating the safety of anti‐amyloid monoclonal antibody infusions in alternative sites of care by Christine Miller, Don Filibeck, Lauren Pica, Barbara Prosser (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712763.txt.

Description

Christine Miller and co-authors published a research paper in 2025 on the safety of giving new Alzheimer's antibody drugs outside big hospitals. The drugs are given by drip and can be delivered at home or at a local infusion center, which saves money and travel. Their pharmacy team reviewed a year of such care across the country.

Thirty patients got 194 infusions in all, some at home and the rest at local centers. About one drip in seven brought a reaction, most often a drop in blood pressure or a headache. No drip had to be stopped, and nurses saw no severe allergy signs. The team reads the record as a good sign for care closer to home.

Catalog record

CREATORChristine Miller, Don Filibeck, Lauren Pica, Barbara Prosser
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11712763

Browse the full library · About the Tower of Babel